Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: a meta-analysis

被引:14
作者
Weinschenker, P
Soares, HP
Clark, O
Del Giglio, A
机构
[1] ABC Fdn Sch Med, Discipline Hematol Oncol, Sao Paulo, Brazil
[2] Inst Radium Campinas, Campinas, SP, Brazil
关键词
breast neoplasms; immunocytochemistry and systematic review; neoplasm; residual;
D O I
10.1007/s10549-004-8691-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. The immunocytochemical detection of epithelial cells in the bone marrow (BM) of breast cancer (BC) patients has been shown to have prognostic importance in several studies. We conducted a systematic review of the literature and a meta-analysis to assess the specificity, rate of positivity and correlation with known prognostic variables as well as with disease free (DFS) and overall survival (OS). Design. We performed a systematic review from the published literature. We included studies with at least 20 previously untreated BC patients as well as non-BC controls that evaluated the presence of epithelial cells in BM using immunocytochemistry (IC). Results. We identified 14 eligible studies with 3253 BC patients and 532 controls. Our results showed that IC has an overall rate of positivity of 31% (95% CI: 30 - 33%), and specificity of 96% ( compared to normal patients) ( 95% CI: 0.94 - 0.98). We observed significant direct correlations between IC BM positivity and the primary tumor's presence with expression of estrogen receptors, larger size and higher histologic grade as well as with the presence of more than 3 positive axillary lymph nodes. At 5 years of follow up IC positivity correlated directly with a lower DFS ( relative risk = 1.60; 95% CI: 1.39 - 1.83) and OS ( relative risk = 1.73; 95% CI: 1.29 - 2.31). The prognostic impact of BM positivity seemed to decrease with time. Conclusions. We conclude that the finding of epithelial cells in BM of BC patients correlates with several known prognostic factors and has adverse impact in the DFS and OS of these patients that seems, however, to decrease with time.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 31 条
[21]   Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study [J].
Mansi, JL ;
Gogas, H ;
Bliss, JM ;
Gazet, JC ;
Berger, U ;
Coombes, RC .
LANCET, 1999, 354 (9174) :197-202
[22]   BONE-MARROW MICROMETASTASES IN PRIMARY BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE AFTER 6 YEARS FOLLOW-UP [J].
MANSI, JL ;
EASTON, D ;
BERGER, U ;
GAZET, JC ;
FORD, HT ;
DEARNALEY, D ;
COOMBES, RC .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) :1552-1555
[23]   Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis [J].
Molino, A ;
Pelosi, G ;
Turazza, M ;
Sperotto, L ;
Bonetti, A ;
Nortilli, R ;
Fattovich, G ;
Alaimo, C ;
Piubello, Q ;
Pavanel, F ;
Micciolo, R ;
Cetto, GL .
BREAST CANCER RESEARCH AND TREATMENT, 1997, 42 (01) :23-30
[24]   Bone marrow micrometastases in breast cancer patients [J].
Molino, A ;
Pelosi, G ;
Micciolo, R ;
Turazza, M ;
Nortilli, R ;
Pavanel, F ;
Cetto, GL .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) :123-130
[25]  
Naume B, 2001, CLIN CANCER RES, V7, P4122
[26]   DIFFERENTIAL EXPRESSION OF PROLIFERATION-ASSOCIATED MOLECULES IN INDIVIDUAL MICROMETASTATIC CARCINOMA-CELLS [J].
PANTEL, K ;
SCHLIMOK, G ;
BRAUN, S ;
KUTTER, D ;
LINDEMANN, F ;
SCHALLER, G ;
FUNKE, I ;
IZBICKI, JR ;
RIETHMULLER, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (17) :1419-1424
[27]   The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19 [J].
Schoenfeld, A ;
Kruger, KH ;
Gomm, J ;
Sinnett, HD ;
Gazet, JC ;
Sacks, N ;
Bender, HG ;
Luqmani, Y ;
Coombes, RC .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) :854-861
[28]  
SOARES HP, 2003, P ASCO
[29]  
Solomayer EF, 2001, CLIN CANCER RES, V7, P4102
[30]   Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance [J].
Stathopoulou, A ;
Vlachonikolis, I ;
Mavroudis, D ;
Perraki, M ;
Kouroussis, C ;
Apostolaki, S ;
Malamos, N ;
Kakolyris, S ;
Kotsakis, A ;
Xenidis, N ;
Reppa, D ;
Georgoulias, V .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) :3404-3412